US cardiac device market to hit $4 billion by the year 2002:
This article was originally published in Clinica
Executive Summary
The US market for implantable cardiac devices is forecast to rise from $1,700 million in 1995 to over $4,000 million by 2002. Increasing demand, combined with the development of smaller, more user-friendly and less invasive devices, are fuelling market growth, says a recent Frost & Sullivan report. Companies which can demonstrate the cost-effectiveness of their products can expect success in the current economic climate, Frost & Sullivan believes.
You may also be interested in...
US Q1 Consumer Health Earnings Preview: Label This One Historic And Challenging But Promising
US OTC drug and supplement firms’ reports of results for the first three months of 2024 began on April 19 with P&G. JP Morgan analysts say while “some retailers in the US in particular” are reducing consumer health inventories, for the overall sector they expect “a healthier balance of positive volume and lower pricing contribution.”
Keeping Track: Cancer Approvals From Lumisight Imaging To Adjuvant Alecensa
The US FDA’s approval of Lumicell’s optical imaging agent Lumisight makes a dozen novel approvals in 2024 for the Center for Drug Evaluation and Research.
Partisan Politics Returns To US FDA Congressional Oversight
The US FDA has stood out as an agency that tends to draw broad bipartisan support amid a generally rancorous and divided Congress. A House hearing, however, may be a sign that those days are over.